Brief: Imricor Medical Systems Recieves FDA Clearance For Northstar
29/01/2026 01:26
Jan 29 (Reuters) - Imricor Medical Systems IMR.AX: IMRICOR RECIEVES FDA CLEARANCE FOR NORTHSTAR® Further company coverage: IMR.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion